跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DARIANTE 2 MG/24 HORAS PARCHES TRANSDÉRMICOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DARIANTE 2 MG/24 HORAS PARCHES TRANSDÉRMICOS EFG
Approved
STANDARD
DARIANTE 2 MG/24 HORAS PARCHES TRANSDÉRMICOS EFG
Exeltis Healthcare S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 17, 2023
Approval ID
458c1fc3b5308117
Company
Exeltis Healthcare S.L.
Type
Standard
Approval Details
Approval Id
458c1fc3b5308117
Drug Cima Aemps Name
DARIANTE 2 MG/24 HORAS PARCHES TRANSDÉRMICOS EFG
Register Number
89090
Holder Company Name
Exeltis Healthcare S.L.
Marketing Company Name
Exeltis Healthcare S.L.
Authorization Date
2023-10-17
Dosage Form
PARCHE TRANSDÉRMICO
Dose
2 mg/24 h
Route Of Administration
VÍA TRANSDÉRMICA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Exeltis Healthcare S.L.
Active Ingredients
ROTIGOTINA
3,68 mg/24 h
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 17, 2023
Approval ID
458c1fc3b5308117
Type
Standard
Back to CIMA-AEMPS Approvals
